WESPAC Advisors’s Cardinal Health CAH Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
Sell
-6,512
Closed -$1.38M 208
2026
Q1
$1.38M Buy
6,512
+238
+4% +$51.3K 0.75% 33
2025
Q4
$1.29M Sell
6,274
-370
-6% -$69.6K 0.7% 43
2025
Q3
$1.04M Buy
6,644
+63
+1% +$9.73K 0.61% 52
2025
Q2
$1.11M Buy
+6,581
New +$977K 0.77% 41

Other funds holding CAH

WESPAC Advisors's CAH Position: Q2 2026 in Review

WESPAC Advisors sold out of Cardinal Health (CAH) in Q2 2026, closing a stake of 6,512 shares — an estimated $1.38M sold.

WESPAC Advisors first reported a position in CAH in Q2 2025 and held it in 4 quarters. The position peaked at $1.38M in Q1 2026. 961 funds tracked by Wall St. Rank hold CAH as of Q2 2026.

  • WESPAC Advisors reported no remaining Cardinal Health position as of Q2 2026 after selling out during the quarter.
  • WESPAC Advisors sold 6,512 Cardinal Health shares in Q2 2026, an estimated $1.38M.
  • WESPAC Advisors first reported a position in Cardinal Health in Q2 2025 and held it in 4 quarters.
  • WESPAC Advisors's Cardinal Health position peaked at $1.38M in Q1 2026.
  • 961 funds tracked by Wall St. Rank held Cardinal Health as of Q2 2026.

Based on WESPAC Advisors's 13F filing for Q2 2026, filed 10 Aug 2026.